Navigation Links
Insmed Initiates Clinical Study for Follow-on Biologic Version of Neulasta(R)
Date:10/14/2008

Company's INS-20 Receives Regulatory Clearance to Begin Phase I Clinical Trial

RICHMOND, Va., Oct. 14 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM), a developer of follow-on biologics and biopharmaceuticals, today announced that it has received approval from the United Kingdom's Medicines and Healthcare products Regulatory Agency (MHRA) to initiate a Phase I clinical study for the Company's second follow-on biologic (FOB) product candidate, INS-20. Insmed's INS-20 is a pegylated recombinant form of human G-CSF, and an FOB of the FDA-approved product Neulasta(R), which had U.S. sales of approximately $2.4 billion in 2007.

Pre-clinical studies demonstrated that INS-20 and FDA-approved Neulasta(R) are comparable in both their pharmacological and toxicological profile. Detailed analytical characterisation also demonstrated that the products have a high degree of similarity. Data from these initial evaluations have been used, in part, to support the Phase I study, which will be initiated immediately. The Phase I study will be conducted in the United Kingdom and will compare the safety and establish the bioequivalence of INS-20 to Neulasta(R). Results from the trial are anticipated in 2009, and are expected to be used as part of a submission to the FDA to establish a protocol with the agency for a Phase III trial.

"We continue to be pleased by the progress we are making in the development of our FOB portfolio, utilizing our unique protein drug development capabilities and technical expertise," said Dr. Geoffrey Allan, President and CEO of Insmed. "Each development milestone we achieve is further evidence of our strong position as a leader in this evolving industry. We intend to use the data to be generated from the Phase I trial, in combination with the positive pre-clinical results previously garnered, as the basis for discussions with the FDA in an effort to establish a Phase III development path for INS-20."

The initiation of t
'/>"/>

SOURCE Insmed Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Insmed CEO to Present at Congressional Briefing on Follow-On Biologics
2. Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company
3. Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs
4. Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R)
5. Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics
6. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
7. Insmed Receives FDA Orphan Drug Designation for IPLEX(TM) in the Treatment of Myotonic Muscular Dystrophy
8. Circassia Initiates Further Phase II Clinical Study of Toleromune(R) Anti-Allergy Technology
9. Baxter Initiates Phase III Trial for the Treatment of Alzheimers Disease
10. S*BIO Initiates U.S. Phase I Clinical Trials of Oral JAK2 Inhibitor SB1518 for the Treatment of Hematological Malignancies
11. Enanta Initiates Phase 1 Study on EDP-322, an Oral Antibiotic With Activity Against Hospital- and Community-Acquired MRSA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... 01, 2015 Research and Markets ( http://www.researchandmarkets.com/research/63gppw/asian_dermatology ... Devices Market by Type, by End User - Forecast to ... Dermatology Devices market is estimated to grow at a CAGR ... holds a larger share in the Dermatology devices market ... . The Asian Dermatology Devices market holds a high potential ...
(Date:5/1/2015)... 2015  Thoratec Corporation (NASDAQ: THOR ), a world ... restore failing hearts, announced today that Marta Antonucci ... International. This new Europe -based ... North America , including Europe ... Latin America , and reports directly to the Chief ...
(Date:5/1/2015)... HABRA, Calif. , May 1, 2015 ... announce its 2015 health literacy award winners. The IHA ... initiatives that make an impact on the practice of ... advance health literacy. IHA gives awards in three categories: ... also bestowed its Health Literacy Hero award. ...
Breaking Medicine Technology:Asian Dermatology Devices (Treatment & Diagnostic) Market by Type, by End User - Forecast to 2019 2Asian Dermatology Devices (Treatment & Diagnostic) Market by Type, by End User - Forecast to 2019 3Thoratec Announces Addition To Senior Management Team 2Thoratec Announces Addition To Senior Management Team 3Institute for Healthcare Advancement Announces 2015 Award Winners 2
... to New Prevention and Treatment Strategies--, PHILADELPHIA, Aug. ... main cause of the inherited version,of the childhood cancer ... play a significant role in high-risk forms of,non-inherited neuroblastoma, ... discovery enables us to offer the first genetic tests ...
... CLL, NHL and CLL Retreatment and Japanese Development Studies ... ... has,announced plans to begin four studies of ofatumumab in chronic lymphocytic,leukemia and ... four studies of,ofatumumab in chronic lymphocytic leukemia (CLL) and follicular,non-Hodgkin,s lymphoma (NHL) ...
Cached Medicine Technology:Gene That Causes Childhood Cancer Neuroblastoma Is Found 2Gene That Causes Childhood Cancer Neuroblastoma Is Found 3Gene That Causes Childhood Cancer Neuroblastoma Is Found 4Genmab Announces Upcoming Ofatumumab Studies 2Genmab Announces Upcoming Ofatumumab Studies 3Genmab Announces Upcoming Ofatumumab Studies 4
(Date:5/2/2015)... 2015 On Tuesday April 7th, the ... gathered to celebrate improvements in patient care. In 2014 ... (RVHP), had zero acquired ventilator associated infections, zero central ... ELCH was also recently named a Top Performer by ... ELCH credited the teamwork of staff from all departments ...
(Date:5/2/2015)... 2015 As a nonsurgical staple ... the face, neck and décolleté, radiofrequency energy is ... potential for the success of vulvovaginal rejuvenation. In ... Advisory Council, ThermiGyn’s Women’s Health Clinical Advisory Board ... that ThermiGyn’s temperature controlled radio frequency, specifically that ...
(Date:5/2/2015)... 2015 With the success that Veatch Dental ... to welcome Neida Miranda and Alex Shields to the team. ... over 41 years of combined experience working with dentists to ... dental field for 8 years. She was certified as ... Customer service, positive attitude and showing the importance of oral ...
(Date:5/1/2015)... BWI (PRWEB) May 02, 2015 The ... It is http://www.thevenetiangracebay.com , and it is elegant ... the stunning white and attractive turquoise hues of Grace ... Google, sixty seven percent of leisure travelers used their ... that smartphones were used in the planning and researching ...
(Date:5/1/2015)... Jusuru International has been awarded the ... of its flagship nutritional supplement, Liquid BioCell™ Life, and ... name, new logo, new packaging, new products, and new ... to identify and promote programs that serve as examples ... congratulates Jusuru International for their outstanding accomplishments and contributions ...
Breaking Medicine News(10 mins):Health News:East Liverpool City Hospital Celebrates Patient Care Improvements 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 3Health News:Veatch Dental Consulting Services Welcomes New Team Members 2Health News:Turks and Caicos Resort, The Venetian on Grace Bay, Launches New Web Presence 2Health News:Jusuru International Receives 2015 DSA Ethos Award 2Health News:Jusuru International Receives 2015 DSA Ethos Award 3Health News:Jusuru International Receives 2015 DSA Ethos Award 4Health News:Jusuru International Receives 2015 DSA Ethos Award 5
... and Heluva Good!® have teamed up for the upcoming May 31, 2009 ... the "Autism Speaks 400, presented by Heluva Good! Sour Cream Dips & ... ... Speedway, Autism Speaks and Heluva Good!® have teamed up for the upcoming ...
... May 7 , ... Palliative Medicine, a new Clinical,Reference Published by Elsevier ... leading publisher of scientific, technical, and,medical information products ... on receiving the American Academy of Hospice and ...
... VPHM ) today announced that Vincent Milano, ... at the Bank of America/Merrill Lynch 2009 Healthcare Conference ... The conference is being held at the Palace ... Rowland, vice president and chief financial officer of ViroPharma ...
... HIV/AIDS EPIDEMIC ABROADMENLO PARK, Calif., May 7 Two-thirds ... U.S. government funding to improve health in developing countries, ... is spending too much on global health, according to ... attitudes towards U.S. global health and development assistance. ...
... better than no treatment at all, study shows , , ... essential for reducing the risk of heart disease and ... matter of debate. , Now, two new analyses attempt ... attacks, all antihypertensive drugs work, with the exception of ...
... NY, May 7, 2009Approximately 6.3 million adultsor one fourth ... unaware they have the disease, and this undiagnosed population ... costs each year, according to a study in a ... peer-reviewed journal published by Mary Ann Liebert, Inc. ( ...
Cached Medicine News:Health News:NASCAR Sprint Cup Series Race at Dover International Speedway Named the "Autism Speaks 400, presented by Heluva Good! Sour Cream Dips & Cheese" 2Health News:NASCAR Sprint Cup Series Race at Dover International Speedway Named the "Autism Speaks 400, presented by Heluva Good! Sour Cream Dips & Cheese" 3Health News:NASCAR Sprint Cup Series Race at Dover International Speedway Named the "Autism Speaks 400, presented by Heluva Good! Sour Cream Dips & Cheese" 4Health News:Author Declan Walsh Honored With National Leadership Award in Palliative Medicine 2Health News:Author Declan Walsh Honored With National Leadership Award in Palliative Medicine 3Health News:ViroPharma to Present at Two May Healthcare Conferences 2Health News:Americans Say Maintain or Increase Funding for Global Health and Development, But Take Care of Problems at Home First in the Recession 2Health News:Americans Say Maintain or Increase Funding for Global Health and Development, But Take Care of Problems at Home First in the Recession 3Health News:Americans Say Maintain or Increase Funding for Global Health and Development, But Take Care of Problems at Home First in the Recession 4Health News:Americans Say Maintain or Increase Funding for Global Health and Development, But Take Care of Problems at Home First in the Recession 5Health News:Americans Say Maintain or Increase Funding for Global Health and Development, But Take Care of Problems at Home First in the Recession 6Health News:All Blood Pressure Drugs Lower Risk of Heart Attack and Stroke 2Health News:All Blood Pressure Drugs Lower Risk of Heart Attack and Stroke 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: